Ming-yen H. Hsieh

100 Tzyou Road, 807
Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: The Kaohsiung journal of medical sciences

Published: April 15, 2026

Predicting non-alcoholic fatty liver disease (NAFLD) using machine learning algorithms: Evidence from a large-scale community cohort in Taiwan.

Predicting non-alcoholic fatty liver disease (NAFLD) using machine learning algorithms: Evidence from a large-scale community cohort in Taiwan.

Journal: Bioscience trends

Published: March 01, 2026

Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.

Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.

Journal: Journal of gastroenterology and hepatology

Published: February 06, 2026

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

Journal: The Kaohsiung journal of medical sciences

Published: January 13, 2026

Ambient nitrogen oxides exposure associated with hepatic steatosis in patients with chronic hepatitis B.

Ambient nitrogen oxides exposure associated with hepatic steatosis in patients with chronic hepatitis B.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: December 24, 2025

Prevalence and associated factors of metabolic dysfunction-associated steatotic liver disease in Taiwan, 2001-2021.

Prevalence and associated factors of metabolic dysfunction-associated steatotic liver disease in Taiwan, 2001-2021.

Journal: Hepatology international

Published: October 07, 2025

FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD.

FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD.

Journal: Journal of gastroenterology and hepatology

Published: August 26, 2025

A Point-of-Care Model for Hepatitis C Elimination in Remote Islands of Taiwan.

A Point-of-Care Model for Hepatitis C Elimination in Remote Islands of Taiwan.

Journal: The Kaohsiung journal of medical sciences

Published: April 02, 2025

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD.

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD.

Journal: The Kaohsiung journal of medical sciences

Published: March 24, 2025

Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis B.

Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis B.

Journal: Journal of the Chinese Medical Association : JCMA

Published: February 13, 2025

Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues.

Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues.

Journal: Alimentary pharmacology & therapeutics

Published: January 02, 2025

Circulating let-7 Predicts Hepatic Fibrogenesis of 12-Month Post-Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus.

Circulating let-7 Predicts Hepatic Fibrogenesis of 12-Month Post-Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus.

Journal: The Kaohsiung journal of medical sciences

Published: December 25, 2024

Showing 1-12 of 114

Last Updated: 09/26/2026